As links between pharmaceutical companies and telehealth providers grow, health policy experts and legislators have sounded ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations of inflated drug prices and rebate-driven formulary exclusions. The agreement bans the PBM ...

Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

ST. LOUIS (CN) — Express Scripts filed a federal lawsuit against the Federal Trade Commission on Tuesday, claiming its report blaming the pharmacy benefit management industry for rising drug costs was ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

Advocates for lower drug prices say a federal lawsuit filed this month against St Louis-based Express Scripts and two other companies could result in more affordable medicine for patients. The Federal ...

Cigna is following through on promises to more aggressively defend its pharmacy benefit manager. On Tuesday, the healthcare company’s PBM, Express Scripts, sued the Federal Trade Commission over the ...

Express Scripts — the largest pharmacy benefit manager in the U.S. — released its 2016 Drug Trend Report showing prescription drug spending slowed for its members last year. Here are four findings ...

The nation's biggest pharmacy benefits manager is muscling back into the debate over soaring drug costs by promoting a less-expensive alternative to a life-saving medicine with a list price of $750 ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts over allegations it inflated drug prices, particularly for insulin, to increase rebates. The deal bans excluding ...